prenatal diagnosis, fetal do & fetal therapy Flashcards
(88 cards)
3 major categories of diagnostic evaluation
fetus high risk for genetic or congenital do
fetus unknown risk from common congenital abnormalities
fetus discovered utz’ly to have structural or dev’tal abnormalities
comprises 8% of conceptuses
most common cause of congenital defect
aneuploidy
aneuploidy accounts for _% 1st trim abortion & _% of all stillbirths & neonatal death
50% & 5-7%
indications for prompt invasive diagnostic procedure
women >35 y/o at delivery
women who previously carried fetus w/ autosomal trisomy
women or their partners who have chromosomal translocation or carriers of chromosomal inversion
hx of triploidy
repetitive spontaneous 1st trim. abortion
parental aneuploidy
intrinsic abnormality programmed in devt regardless of whether a precise genetic etiology is known
malformation
genetically normal fetus develops abnormally of mechanical forces imposed by uterine mvmt
deformation
more severe changes in form of fx occurs when genetically normal tissue is modified as result of specific insult
disruption
multiple structural or dev’tal abnormalities occurring together in one individual; can have same cause (give 1 ex)
syndrome (trisomy 18)
all anomalies developed sequentially as a result of one initial result (give 1 ex)
sequence (oligohydramnios leading to pulmo hypoplasia, limb contracture & facial deformities)
particular anomalies occur together frequently but do not seem to be linked etiologically (give 1 ex)
association (VATER)
(3) components of combined 1st trim. screening performed during _wks
hCG
PAPP-A
NT on utz
(11 & 14 wks)
what can be offered if NT measurement is at least 3mm or exceeds 99th percentile?
targeted sonography w/ fetal echocardiography
(4) components of quad screening testing performed during _wks
MSAFP hCG inhibin estriol (15-21 wks)
quad screening result in down syndrome
low MSAFP
high hCG
low estriol
high inhibin
women at high risk of pregnancy w/ NTD are offered w/? (2)
targeted sonography and mAFP testing
this marker is a glycoprotein synthesized by YS in early gestation then later on by liver and fetal GIT
AFP
upper limit of normal in MSAFP
2.5 MoM
differentiate screening from diagnostic test
S: provide information not to dictate a course of action
D: provides info that screening does not
conditions associated w/ elevated MSAFP
underestimated GA multifetal gestation fetal death MTD gastroschisis omphalocele cystic hygroma intestinal obstruction liver necrosis renal anomalies cloacal exstrophy OI sacrococcygeal teratoma congenital skin abnormality pilonidal cyst chorioangioma of placenta placenta intervillous thrombosis placental abruption oligohydramnios preeclampsia fetal growth restriction maternal hepatoma or teratoma
low estriol is associated w/ 2 uncommon but important condition
smith-lemli-opitz syndrome
c-linked ichthyosis
differentiate integrated & sequential screening
I: combined 1st trim screening + quad screening; aneuploidy risk is calculated from 7 parameters
S: combined 1st trim screening then inform px w/ result. if the risk is above threshold, she’ll receive counseling and offered dx testing
differentiate stepwise & contingent sequential screening
S: high risk are offered invasive testing and the remaining receive 2nd trim. screening
C: highest risk are offered invasive testing; moderate risk receive 2nd trim. screening; lowest risk & negative result have no further testing
this test works by identifying DNA fragments derived from apoptotic trophoblast and can be performed anytime after _wks?
cell-free dna screening (9-10wks)
if cell-free dna screening is performed as secondary screening, a normal result is reassuring, Tor F?
false (not reassuring)